title: Thalidomide in the treatment of immune reconstitution inflammatory syndrome in HIV patients with neurological tuberculosis.
authors.affiliation: 1 Infectious and Tropical Diseases Unit, Nîmes University Hospital , Nîmes, France .
authors.forename: Camille
authors.initials: C
authors.lastname: Fourcade
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Mauboussin
authors.forename: Catherine
authors.initials: C
authors.lastname: Lechiche
authors.forename: Jean-Philippe
authors.initials: JP
authors.lastname: Lavigne
authors.forename: Albert
authors.initials: A
authors.lastname: Sotto
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000276:immunology; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D000995:Antitubercular Agents / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000276:immunology / Q000302:isolation & purification; D009422:Nervous System Diseases / Q000188:drug therapy / Q000209:etiology* / Q000523:psychology; D009460:Neurologic Examination; D010291:Paresis / Q000209:etiology; D013792:Thalidomide / Q000627:therapeutic use*; D016896:Treatment Outcome; D014376:Tuberculosis / Q000150:complications* / Q000188:drug therapy
chemical_list: D044966:Anti-Retroviral Agents; D000995:Antitubercular Agents; D007166:Immunosuppressive Agents; D013792:Thalidomide